Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Deciphera Pharmaceuticals Inc (DCPH)

Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,212,921
  • Shares Outstanding, K 86,476
  • Annual Sales, $ 163,360 K
  • Annual Income, $ -194,940 K
  • EBIT $ -207 M
  • EBITDA $ -204 M
  • 60-Month Beta 0.19
  • Price/Sales 13.54
  • Price/Cash Flow N/A
  • Price/Book 6.66
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.21
  • Most Recent Earnings $-0.52 on 05/10/24
  • Next Earnings Date 05/15/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.55
  • Number of Estimates 7
  • High Estimate -0.45
  • Low Estimate -0.66
  • Prior Year -0.57
  • Growth Rate Est. (year over year) +3.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.38 +0.83%
on 05/13/24
25.61 -0.08%
on 06/10/24
+0.23 (+0.91%)
since 05/10/24
3-Month
14.00 +82.79%
on 04/25/24
25.61 -0.08%
on 06/10/24
+8.65 (+51.06%)
since 03/08/24
52-Week
9.90 +158.48%
on 10/25/23
25.61 -0.08%
on 06/10/24
+11.57 (+82.52%)
since 06/09/23

Most Recent Stories

More News
Tesla, Domino's Pizza rise; AMC Entertainment, SoFi Technologies fall, Monday, 4/29/2024

Stocks that traded heavily or had substantial price changes on Monday: Tesla, Domino’s Pizza rise; AMC Entertainment, SoFi Technologies fall

FULT : 20.84 (+0.63%)
DCPH : 25.59 (+0.08%)
UMBF : 120.19 (-0.83%)
DPZ : 438.97 (-0.19%)
Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

/PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in...

DCPH : 25.59 (+0.08%)
Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

/CNW/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international...

DCPH : 25.59 (+0.08%)
3 Under-the-Radar Biotech Stocks to Buy in 2023

All three biotech companies focus on oncology therapies.

DCPH : 25.59 (+0.08%)
MRTX : 58.70 (-0.17%)
MGNX : 3.28 (-5.75%)
Why Shares of Deciphera Pharmaceuticals Rose This Week

The company's shares rose after the company reported second-quarter earnings.

DCPH : 25.59 (+0.08%)
Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.59 (+0.08%)
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.59 (+0.08%)
Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.59 (+0.08%)
Deciphera Pharmaceuticals to Present at the Stifel Virtual Targeted Oncology Days

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.59 (+0.08%)
Why Deciphera Pharmaceuticals Stock Jumped This Week

The company's lead therapy received an FDA Breakthrough Therapy designation.

DCPH : 25.59 (+0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Deciphera Pharmaceuticals, Inc. develops small molecule kinase inhibitors for cancer, utilizing its proprietary kinase switch control inhibitor platform.

See More

Key Turning Points

3rd Resistance Point 25.66
2nd Resistance Point 25.64
1st Resistance Point 25.61
Last Price 25.59
1st Support Level 25.56
2nd Support Level 25.54
3rd Support Level 25.51

See More

52-Week High 25.61
Last Price 25.59
Fibonacci 61.8% 19.61
Fibonacci 50% 17.76
Fibonacci 38.2% 15.90
52-Week Low 9.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar